DSM Biologics To Create BioPharmaceuticals Australia For Outsourcing
This article was originally published in PharmAsia News
Executive Summary
Australia is to have its first major contract-manufacturing plant for producing biologic drugs after luring DSM Biologics with more than $15.6 million in government funds